JACOBS LEVY EQUITY MANAGEMENT, INC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 131 filers reported holding CYTOKINETICS INC in Q3 2017. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2021$1,001,000
-59.2%
50,570
-55.4%
0.01%
-72.0%
Q3 2020$2,454,000
-58.2%
113,330
-54.5%
0.02%
-60.9%
Q2 2020$5,874,000
-28.7%
249,207
-64.3%
0.06%
-39.6%
Q1 2020$8,238,000
+51.7%
698,752
+36.5%
0.11%
+100.0%
Q4 2019$5,429,000
+205.3%
511,730
+132.9%
0.05%
+103.8%
Q1 2019$1,778,000
+92.4%
219,736
+50.3%
0.03%
+62.5%
Q4 2018$924,000
-10.2%
146,236
+40.0%
0.02%
+6.7%
Q3 2018$1,029,000
+40.2%
104,436
+18.1%
0.02%
+25.0%
Q2 2018$734,000
+29.5%
88,398
+12.2%
0.01%
+33.3%
Q1 2018$567,000
+44.3%
78,800
+142.7%
0.01%
+12.5%
Q2 2017$393,000
+87.1%
32,464
+46.7%
0.01%
+100.0%
Q2 2016$210,000
-59.8%
22,130
-70.1%
0.00%
-63.6%
Q1 2016$522,000
-40.2%
74,087
-11.3%
0.01%
-35.3%
Q4 2015$873,000
+15.5%
83,487
-26.1%
0.02%
+6.2%
Q3 2015$756,000
+59.2%
112,987
+59.7%
0.02%
+77.8%
Q2 2015$475,000
-39.7%
70,746
-39.1%
0.01%
-30.8%
Q1 2015$788,000
-55.8%
116,246
-47.8%
0.01%
-58.1%
Q4 2014$1,784,000
+355.1%
222,781
+99.9%
0.03%
+342.9%
Q3 2014$392,000
-77.3%
111,446
-38.8%
0.01%
-75.9%
Q1 2014$1,730,000
+110.5%
182,100
+44.0%
0.03%
+141.7%
Q4 2013$822,000
+145.4%
126,430
+185.9%
0.01%
+100.0%
Q3 2013$335,00044,2150.01%
Other shareholders
CYTOKINETICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders